Tag: FcRn
-
How Etentamig Redirects T Cells in Multiple Myeloma
Etentamig is a BCMA × CD3 bispecific T-cell engager designed with bivalent BCMA binding, low-affinity CD3 engagement and retained FcRn binding to redirect T cells against multiple myeloma cells.
-
Vyvgart Moves Into Autoimmune Muscle Disease After Phase 3 Win
Vyvgart Hytrulo met the primary endpoint in the Phase 3 ALKIVIA study, strengthening argenx’s case for expanding FcRn inhibition into autoimmune muscle disease.